Kim van Kol

Mrs. Kim van Kol


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 February 2023 in Gynecologic Oncology
Verified
Journal Article
Closed access
KKKim van Kol
Kim van Kol
RER.M.F. Ebisch
R.M.F. Ebisch
MAM. van der Aa
M. van der Aa
HWH.B. Wenzel
H.B. Wenzel
JPJ.M.J. Piek
J.M.J. Piek
RBR.L.M. Bekkers
R.L.M. Bekkers

31 December 2023 in Cancers
Verified
Journal Article
Open access
PDF file
KKKim van Kol
Kim van Kol
RERenée Ebisch
Renée Ebisch
MBMaaike Beugeling
Maaike Beugeling
JCJeltsje Cnossen
Jeltsje Cnossen
JNJ. (Joost) Nederend
J. (Joost) Nederend
Ruud BekkersRuud Bekkers
Ruud Bekkers
Objectives: There is no consensus on the most reliable procedure to determine remission of cervical cancer after chemoradiotherapy (CRT). Therefore, this study aims to assess the diagnostic performance of two different imaging techniques, MRI and 18F[FDG]-PET/CT, in determining the presence of locoregional residual disease after CRT in patients with locally advanced cervical cancer. Methods: Patients diagnosed with locally advanced cervical cancer (FIGO 2009) treated with CRT were retrospectively identified from a regional cohort. The accuracy of MRI and 18F[FDG]-PET/CT in detecting locoregional residual disease was assessed with histology as the reference standard. Results: The negative predictive value (NPV) and positive predictive value (PPV) for locoregional residual disease detection of MRI and 18F[FDG]-PET/CT combined were 84.2% (95% CI 73.2–92.1), and 70.4% (95% CI 51.8–85.2), respectively. The NPV and PPV of MRI alone were 80.2% (95% CI 71.2–87.5) and 47.7% (95% CI 35.8–59.7), respectively, and values of 81.1% (95% CI 72.2–88.3) and 55.8 (95% CI 42.2–68.7), respectively, were obtained for 18F[FDG]-PET/CT alone. Conclusion: In this study, the reliability of MRI and 18F[FDG]-PET/CT in detecting locoregional residual disease was limited. Combining MRI and 18F[FDG]-PET/CT did not improve predictive values. Routine use of both MRI and 18F[FDG]-PET/CT in the follow-up after CRT should be avoided. MRI during follow-up is the advised imaging technique. Pathology confirmation of the presence of locoregional residual disease before performing salvage surgery is warranted.